Nuclear actin-dependent Meg3 expression suppresses metabolic genes by affecting the chromatin architecture at sites of elevated H3K27 acetylation levels
Nucleic Acids Research · 2025
DOI: 10.1093/nar/gkaf280 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Nadine Hosny El Said und 5 weiteren Autor:innen. Beteiligte Einrichtung: Program in Biology, Division of Science and Mathematics, New York University Abu Dhabi (NYUAD), PO Box 129188, Abu Dhabi, United Arab Emirates. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Actins, Histones, Chromatin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: New York University Abu Dhabi, NYU Abu Dhabi Research Institute, NYU Abu Dhabi Center for Genomics and Systems Biology.
Abstract (Originalsprache)
Nuclear actin mediates enhancer-dependent transcriptional regulation at compartment level, playing critical roles in 3D genome organization. In β-actin depleted cells, H3K27 acetylation is enhanced, directly affecting enhancer-dependent transcriptional regulation and gene expression changes during compartment-switching. Here, we report these mechanisms are influenced by the long non-coding RNA (lncRNA) Meg3. Bulk RNA-seq analysis and qPCR on wild-type (WT), heterozygous (HET), and β-actin knockout (KO) mouse embryonic fibroblasts (MEFs) show that β-actin depletion significantly alters expression of several lncRNAs, including Meg3. Results from ChIRP-seq, ChIRP-MS, and fRIP-qPCR revealed that in β-actin KO cells, Meg3 becomes enriched and binds to H3K27 acetylation marks within gene regulatory regions. By integrating RNA-seq, H3K27 acetylation ChIP-seq, ATAC-seq, and HiC-seq data through activity by contact (ABC) analysis, we discovered Meg3 binding disrupts promoter–enhancer interactions in β-actin KO cells. These results, combined with metabolomics in WT, HET, and β-actin KO MEFs, show Meg3 binding to regulatory regions at sites of increased H3K27 acetylation impairs the expression of genes involved in the synthesis of chondroitin, heparan, dermatan sulfate, and phospholipases. We propose that in β-actin KO cells Meg3 binds to H3K27 acetylation levels. This interferes with promoter–enhancer interactions, disrupts genome organization, and downregulates gene expression and key metabolic pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Program in Biology, Division of Science and Mathematics, New York University Abu Dhabi (NYUAD), PO Box 129188, Abu Dhabi, United Arab Emirates.
- Center for Genomics and Systems Biology, New York University Abu Dhabi (NYUAD), PO Box 129188, Abu Dhabi, United Arab Emirates.
ORCID-Profile: Piergiorgio Percipalle
Förderung
- New York University Abu Dhabi
- NYU Abu Dhabi Research Institute
- NYU Abu Dhabi Center for Genomics and Systems Biology
Zitieren
APA
Hosny El Said, N., Abdrabou, W., Mahmood, S. R., Venit, T., Idaghdour, Y., & Percipalle, P. (2025). Nuclear actin-dependent Meg3 expression suppresses metabolic genes by affecting the chromatin architecture at sites of elevated H3K27 acetylation levels. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf280
Vancouver
Hosny El Said N, Abdrabou W, Mahmood SR, Venit T, Idaghdour Y, Percipalle P. Nuclear actin-dependent Meg3 expression suppresses metabolic genes by affecting the chromatin architecture at sites of elevated H3K27 acetylation levels. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf280
BibTeX
@article{HosnyElSaid2025,
author = {Hosny El Said, Nadine and Abdrabou, Wael and Mahmood, Syed Raza and Venit, Tomas and Idaghdour, Youssef and Percipalle, Piergiorgio},
title = {Nuclear actin-dependent Meg3 expression suppresses metabolic genes by affecting the chromatin architecture at sites of elevated H3K27 acetylation levels},
journal = {Nucleic Acids Research},
year = {2025},
doi = {10.1093/nar/gkaf280}
}
EUVIMED